On Chemball
My Chemball
+86-571-8627 3270
Jiangsu Zhongbang Pharmaceutical Co., Ltd.
Jiangsu Zhongbang Pharmaceutical Co., Ltd.
23 YRS
Jiangsu, China
Main Products:
Telmisartan / Irbesartan / Olmesartan Medoxomi / Valsartan / Candesartan Cilexetil / Esomeprazole Magnesium Trihydrate / Sodium (S)-6-Methoxy-2-(((4-Methoxy-3,5-Dimethylpyridin-2-yl)Methyl)Sulfinyl)Benzo[d]Imidazol-1-ide / Lansoprazole / 5-Methoxy-2-{[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)Methyl]Sulfinyl}-1H-Benzimidazole / Nevirapine / Efavirenz
Jiangsu, China
Send Email
Sending...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
Telmisartan
Irbesartan
Olmesartan Medoxomi
Valsartan
Candesartan Cilexetil
Esomeprazole Magnesium Trihydrate
Sodium (S)-6-Methoxy-2-(((4-Methoxy-3,5-Dimethylpyridin-2-yl)Methyl)Sulfinyl)Benzo[d]Imidazol-1-ide
Lansoprazole
5-Methoxy-2-{[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)Methyl]Sulfinyl}-1H-Benzimidazole
Nevirapine
Efavirenz
ABOUT US
Jiangsu Zhongbang Pharmaceutical Co., Ltd., founded in 2001, is a wholly-owned subsidiary of China's top 500 enterprises - Red Sun Group. Zhongbang pharmaceutical is a proposed listed company specializing in R & D, production and sales of APIs, advanced pharmaceutical intermediates and pharmaceutical preparations. The company has a registered capital of 180 million yuan. It now has four wholly-owned subsidiaries with more than 700 employees, covering a total area of more than 500 mu.
Zhongbang pharmaceutical mainly produces cardiovascular and cerebrovascular drugs, digestive system drugs, anticoagulant drugs and other pharmaceutical intermediates, APIs and preparations. The products sell well in domestic and foreign markets and are recognized and praised by customers.
Quality is the inherent value pursuit of Chinese people. Perfect GMP management system, complete production facilities and equipment, advanced testing instruments and information system ensure excellent and reliable product quality. The company has passed the GMP on-site inspection in China, South Korea, Japan and other countries, and many API have EU CEP certificate and China GMP certificate.
Innovation is becoming the engine of China's development. Up to now, the company has 22 national invention patents and 2 preparation products are under approval. It has been recognized as Jiangsu heterocyclic medicine and intermediate engineering technology research center, enterprise technology center and innovation pilot enterprise, providing satisfactory products and services for world-famous pharmaceutical enterprises.
Zhongbang pharmaceutical takes social responsibility as its own responsibility, adheres to the business philosophy of "achieving capable people, loving good people and repaying noble people", and firmly remembers the mission of "never forgetting the original intention, happy employees and repaying society", so as to provide customers with high-quality products and services and contribute to the cause of human health.
Basic Information
Tax ID
91320118733184169M
Country/Region
Jiangsu, China
Year Established
2001
Registered Capital
CNY 180 Million
Business Type
Manufacturing
Total Employees
500-1000 people
Quality Management Certificate
ISO9001,
SFDA-GMP,
CEP/COS
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
Zhongbang pharmaceutical mainly produces cardiovascular and cerebrovascular drugs, digestive system drugs, anticoagulant drugs and other pharmaceutical intermediates, APIs and preparations.
PLANT LOCATION
COMPANY ALBUM
){kind=link}
